McKinsey has agreed to pay $650 million to settle a federal investigation into its role in boosting OxyContin sales for Purdue Pharma, accepting accountability for its actions.
Martin Elling, a former McKinsey partner, has pled guilty to obstruction of justice for deleting documents pertinent to investigations regarding Purdue Pharma.
In its statement, McKinsey expressed profound regret for its role in the opioid crisis, acknowledging it should have recognized the harm opioids cause to society.
The latest federal efforts are aimed at addressing the addiction crisis fueled by companies like Purdue Pharma, with opioids contributing to over 80,000 deaths annually.
Collection
[
|
...
]